Cold Pain Therapy Market (by Product: (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription Devices (Motorized, Non-Motorized), Applications (Musculoskeletal, Post Op, Sports Medicine), Distribution Channel(Hospital, Retail) - Global Industry Analysis, Share ,Growth ,Regional Outlook And Forecasts, 2021-2027

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Cold Pain Therapy Market, By Product

7.1.  Cold Pain Therapy Market, By Product, 2021-2027

7.1.1.     OTC Products

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Cold Packs

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Cooling Towels, Compresses, Wraps, and Pads

7.1.3.1.          Market Revenue and Forecast (2016-2027)

7.1.4.     Prescription Products

7.1.4.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global Cold Pain Therapy Market, Regional Estimates and Trend Forecast

8.1.  North America

8.1.1.     Market Revenue and Forecast, By Product (2016-2027)

8.1.2.     U.S.

8.1.3.     Rest of North America

8.1.3.1.          Market Revenue and Forecast, By Product (2016-2027)

8.2.  Europe

8.2.1.     Market Revenue and Forecast, By Product (2016-2027)

8.2.2.     UK

8.2.2.1.          Market Revenue and Forecast, By Product (2016-2027)

8.2.3.     France

8.2.3.1.          Market Revenue and Forecast, By Product (2016-2027)

8.2.4.     Rest of Europe

8.2.4.1.          Market Revenue and Forecast, By Product (2016-2027)

8.3.  APAC

8.3.1.     Market Revenue and Forecast, By Product (2016-2027)

8.3.2.     India

8.3.2.1.          Market Revenue and Forecast, By Product (2016-2027)

8.3.3.     China

8.3.3.1.          Market Revenue and Forecast, By Product (2016-2027)

8.3.4.     Japan

8.3.4.1.          Market Revenue and Forecast, By Product (2016-2027)

8.3.5.     Rest of APAC

8.3.5.1.          Market Revenue and Forecast, By Product (2016-2027)

8.4.  MEA

8.4.1.     Market Revenue and Forecast, By Product (2016-2027)

8.4.2.     GCC

8.4.2.1.          Market Revenue and Forecast, By Product (2016-2027)

8.4.3.     North Africa

8.4.3.1.          Market Revenue and Forecast, By Product (2016-2027)

8.4.4.     South Africa

8.4.4.1.          Market Revenue and Forecast, By Product (2016-2027)

8.4.5.     Rest of MEA

8.4.5.1.          Market Revenue and Forecast, By Product (2016-2027)

8.5.  Latin America

8.5.1.     Market Revenue and Forecast, By Product (2016-2027)

8.5.2.     Brazil

8.5.2.1.          Market Revenue and Forecast, By Product (2016-2027)

8.5.3.     Rest of LATAM

8.5.3.1.          Market Revenue and Forecast, By Product (2016-2027)

Chapter 9.      Company Profiles

9.1.  Sanofi (France)

9.1.1.     Company Overview

9.1.2.     Product Offerings

9.1.3.     Financial Performance

9.1.4.     Recent Initiatives

9.2.  Pfizer (US)

9.2.1.     Company Overview

9.2.2.     Product Offerings

9.2.3.     Financial Performance

9.2.4.     Recent Initiatives

9.3.  Hisamitsu Pharmaceutical (Japan)

9.3.1.     Company Overview

9.3.2.     Product Offerings

9.3.3.     Financial Performance

9.3.4.     Recent Initiatives

9.4.  ROHTO Pharmaceutical (Japan)

9.4.1.     Company Overview

9.4.2.     Product Offerings

9.4.3.     Financial Performance

9.4.4.     Recent Initiatives

9.5.  Beiersdorf (Germany)

9.5.1.     Company Overview

9.5.2.     Product Offerings

9.5.3.     Financial Performance

9.5.4.     Recent Initiatives

9.6.  Johnson & Johnson (US)

9.6.1.     Company Overview

9.6.2.     Product Offerings

9.6.3.     Financial Performance

9.6.4.     Recent Initiatives

9.7.  Medline Industries (US)

9.7.1.     Company Overview

9.7.2.     Product Offerings

9.7.3.     Financial Performance

9.7.4.     Recent Initiatives

9.8.  Össur (Iceland)

9.8.1.     Company Overview

9.8.2.     Product Offerings

9.8.3.     Financial Performance

9.8.4.     Recent Initiatives

9.9.  Performance Health (US)

9.9.1.     Company Overview

9.9.2.     Product Offerings

9.9.3.     Financial Performance

9.9.4.     Recent Initiatives

9.10.                 Breg (US)

9.10.1.  Company Overview

9.10.2.  Product Offerings

9.10.3.  Financial Performance

9.10.4.  Recent Initiatives

9.11.                 Romsons Group of Industries (India)

9.11.1.  Company Overview

9.11.2.  Product Offerings

9.11.3.  Financial Performance

9.11.4.  Recent Initiatives

9.12.                 Unexo Life Sciences (India)

9.12.1.  Company Overview

9.12.2.  Product Offerings

9.12.3.  Financial Performance

9.12.4.  Recent Initiatives

9.13.                 Bird & Cronin (US)

9.13.1.  Company Overview

9.13.2.  Product Offerings

9.13.3.  Financial Performance

9.13.4.  Recent Initiatives

Chapter 10.   Research Methodology

10.1.                 Primary Research

10.2.                 Secondary Research

10.3.                 Assumptions

Chapter 11.   Appendix

11.1.                 About Us

11.2.                 Glossary of Terms